FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileNeuroScientific Biopharmaceuticals Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NSB.AX
NeuroScientific Biopharmaceuticals Limited Stock AnalysisComprehensive stock analysis for NeuroScientific Biopharmaceuticals Limited (NSB.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNSB.AX
NSB.AX
NeuroScientific Biopharmaceuticals Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
NSB.AX
  1. Home
  2. Stocks
  3. NeuroScientific Biopharmaceuticals Limited

NeuroScientific Biopharmaceuticals Limited

🇦🇺NSB.AX•ASX

NeuroScientific Biopharmaceuticals Limited

🇦🇺NSB.AX•ASX

Your view on NSB.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About NeuroScientific Biopharmaceuticals Limited

Industry
Biotechnology
Sector
Healthcare
CEO
Nathan Smith
Headquarters
216 St Georges Terrace, Perth, WA, AU
Industry
Biotechnology
Sector
Healthcare
CEO
Nathan Smith
Headquarters
216 St Georges Terrace, Perth, WA, AU
Description

Established in 2002 and headquartered in Cottesloe, Australia, NeuroScientific Biopharmaceuticals Limited specializes in the development of medical therapies for neurodegenerative conditions. The company conducts extensive preclinical and clinical research utilizing its proprietary technological platforms to advance these treatments.

Its primary pharmaceutical compound, EmtinB, is being developed as a potential therapeutic agent for diseases including neurodegenerative dementia, Alzheimer's disease, and various degenerative disorders affecting the optic nerve.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for NeuroScientific Biopharmaceuticals Limited. Starting points for NeuroScientific Biopharmaceuticals Limited: EPS -AUD 0.01, beta 1.12 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for NeuroScientific Biopharmaceuticals Limited. NeuroScientific Biopharmaceuticals Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for NeuroScientific Biopharmaceuticals Limited. Trailing twelve-month EPS for NeuroScientific Biopharmaceuticals Limited stands at -AUD 0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for NeuroScientific Biopharmaceuticals Limited. NeuroScientific Biopharmaceuticals Limited has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold NSB.AX12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
OSRHWOSR Holdings, Inc.HealthcareNASDAQ$7.8M
OSTXOS Therapies IncorporatedHealthcareAMEX$42.0M
OTLCOncotelic Therapeutics, Inc.HealthcareOTC$21.2M
OTLKOutlook Therapeutics, Inc.HealthcareNASDAQ$94.9M
OVIDOvid Therapeutics Inc.HealthcareNASDAQ$415.2M
OXBOFOxford BioDynamics PlcHealthcareOTC$4.3M
OZYMFStrategic Partners A/SHealthcareOTC$3.7M
PAB.AXPatrys LimitedHealthcareASX—
PALIPalisade Bio, Inc.HealthcareNASDAQ$150.6M
PANCPanacos Pharmaceuticals, Inc.HealthcareOTC$5,367
PAR.AXParadigm Biopharmaceuticals LimitedHealthcareASX—
PARDPoniard Pharmaceuticals, Inc.HealthcareOTC$150
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for NeuroScientific Biopharmaceuticals Limited. Coverage tracks NeuroScientific Biopharmaceuticals Limited within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of NeuroScientific Biopharmaceuticals Limited.

NSB.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1